Similar articles for PMID: 29879220

Year	Number of Results
1997	1
1999	1
2001	1
2002	3
2006	1
2007	1
2008	1
2010	2
2011	4
2012	4
2013	5
2014	8
2015	7
2016	8
2017	13
2018	10
2019	23
2020	7
2021	2
2022	2
2023	1
2024	0

1

Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma.

Egawa Y, Saigo C, Kito Y, Moriki T, Takeuchi T. Egawa Y, et al. PLoS One. 2018 Jun 7;13(6):e0198940. doi: 10.1371/journal.pone.0198940. eCollection 2018. PLoS One. 2018. PMID: 29879220 Free PMC article.

2

CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling.

Gao L, Xu Z, Huang Z, Tang Y, Yang D, Huang J, He L, Liu M, Chen Z, Teng Y. Gao L, et al. J Exp Clin Cancer Res. 2020 Apr 28;39(1):73. doi: 10.1186/s13046-020-01579-x. J Exp Clin Cancer Res. 2020. PMID: 32345326 Free PMC article.

3

Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling.

Nakai S, Tamiya H, Imura Y, Nakai T, Yasuda N, Wakamatsu T, Tanaka T, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Yoshikawa H, Naka N. Nakai S, et al. Mol Cancer Ther. 2020 Mar;19(3):742-754. doi: 10.1158/1535-7163.MCT-19-0358. Epub 2019 Dec 3. Mol Cancer Ther. 2020. PMID: 31796507

4

Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.

Hakozaki M, Tamura H, Dobashi Y, Yoshida A, Kato K, Tajino T, Yamada H, Kaneuchi Y, Katahira K, Ezaki J, Waguri S, Konno S, Watanabe S. Hakozaki M, et al. Anticancer Res. 2018 Sep;38(9):5035-5042. doi: 10.21873/anticanres.12822. Anticancer Res. 2018. PMID: 30194147

5

Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.

Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Sakumoto M, et al. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. In Vitro Cell Dev Biol Anim. 2018. PMID: 29197033

6

Pharmacologic treatment with CPI-613 and PS48 decreases mitochondrial membrane potential and increases quantity of autolysosomes in porcine fibroblasts.

Mordhorst BR, Kerns KC, Schauflinger M, Zigo M, Murphy SL, Ross RM, Wells KD, Green JA, Sutovsky P, Prather RS. Mordhorst BR, et al. Sci Rep. 2019 Jul 1;9(1):9417. doi: 10.1038/s41598-019-45850-4. Sci Rep. 2019. PMID: 31263141 Free PMC article.

7

The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.

Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL, Chang JC. Liang DH, et al. Cancer Lett. 2016 Jul 1;376(2):249-58. doi: 10.1016/j.canlet.2016.04.002. Epub 2016 Apr 6. Cancer Lett. 2016. PMID: 27060208 Free PMC article.

8

An obstructive role of NK cells on metastatic growth of clear-cell sarcoma cells in a xenoplant murine model.

Hanamatsu Y, Saigo C, Kito Y, Takeuchi T. Hanamatsu Y, et al. Mol Clin Oncol. 2021 Jan;14(1):9. doi: 10.3892/mco.2020.2171. Epub 2020 Nov 12. Mol Clin Oncol. 2021. PMID: 33262889 Free PMC article.

9

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

Pardee TS, Lee K, Luddy J, Maturo C, Rodriguez R, Isom S, Miller LD, Stadelman KM, Levitan D, Hurd D, Ellis LR, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. Pardee TS, et al. Clin Cancer Res. 2014 Oct 15;20(20):5255-64. doi: 10.1158/1078-0432.CCR-14-1019. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165100 Free PMC article. Clinical Trial.

10

Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo.

Zachar Z, Marecek J, Maturo C, Gupta S, Stuart SD, Howell K, Schauble A, Lem J, Piramzadian A, Karnik S, Lee K, Rodriguez R, Shorr R, Bingham PM. Zachar Z, et al. J Mol Med (Berl). 2011 Nov;89(11):1137-48. doi: 10.1007/s00109-011-0785-8. Epub 2011 Jul 19. J Mol Med (Berl). 2011. PMID: 21769686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year